On Demand Webinars
ICH Q3E Impurity Guidelines: Assessment and Control of Extractractables and Leachables for Pharmaceuticals and Biologics.
Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Philippe Verlinde, Ph.D. Ir. Senior Scientist - Study Director at Nelson Labs
14th September 2022
Challenges In Therapeutic Biological Products
Presented by Paolo Grisostomi, Senior Engineer, Materials Science at Biogen and Donald Young, Sr. Product Manager at Thermo Fisher Scientific and Dr. Sona Kovackova, Study Director Small Volume Parenteral applications, Nelson Labs Europe
18th August 2022
Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L
Presented by John Ketz, Process Development Senior Scientist, Andelyn Biosciences, Denis Kole, Director - AcceleratorSM Processes Development Services, Pall Corporation and Benben Song, Product Manager Services, Pall Corporation
12th July 2022
Single Use Process for Production of AAV Gene Therapy Products
Presented by Lance Marquardt, Associate Director -Upstream Processing Gene Therapy, Hopewell Biologics Manufacturing at PTC Therapeutics, Vikas Gupta, Vice President and GM Downstream Bioprocessing and Gene Therapy, Rachel Legmann, Senior Director of Technology, Gene Therapy at Repligen and Gilbert Huang, Senior Field Application Scientist at Repligen
26th May 2022
Material Requirements to Support Gene Therapy Development
Presented by Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn
19th May 2022
The Use of Stability Modelling to Support Accelerated Vaccine Development & Supply
Presented by Didier Clenet, Research Scientist Formulation & Stability chez Sanofi Pasteur, Jos Weusten, Senior Statistician and Applied Mathematician at MSD (Oss, The Netherlands), Marilena Paludi, Lead Statistician presso GSK, and Cristiana Campa, Technical R&D Advisor at GSK
16th May 2022
From Product Characterization to Clinical Reliable Specifications
Presented by André Mischo, Associate Director Science & Technology at Novartis
11th May 2022
Shortages of critical raw materials and managing changes and substitutions
Presented by Frances Sexton – TS/MS Bioprocess Chemist – Materials Management, Eli Lilly and Dennis Jenke, Chief Executive Scientist at Triad Scientific Solutions on Behalf of Nelson Labs
28th April 2022
Data as an asset – what does this mean to you?
Presented by Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning at The Janssen Pharmaceutical Companies of Johnson & Johnson and Klaus Mauch, CEO at Yokogawa Insilico Biotechnology GmbH
12th April 2022
Interface Machine Learning Process Analytical Technology and Process Science For Next Level Process Development.
Presented by Oliver Steinhof, Senior Scientist Process Analytical Technologies (PAT) at Biogen and Martin Gadsby, Owner, Optimal Industrial Technologies Ltd
05th April 2022
